PATENT CLAIM ANALYSIS

Application Number: 15869630
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["435", "325000"]

Abstract:
The invention provides regimens and methods for the treatment of cancer comprising continuous infusion of coenzyme Q10. The coenzyme Q10 may be administered as a monotherapy, or in combination with an additional agent, such as an anticancer agent, a chemotherapeutic agent, or an anti-angiogenic agent. The coenzyme Q10 may be administered at two or more different rates.

Claim (Index 8):
The method of  claim 3 , wherein the total time of the infusion at the first rate plus the time of the infusion at the second rate is about 24 hours, about 48 hours, or about 72 hours.

Metadata:
- Claim Count in Document: 188.0
- Percentile: 86.0
- Lexical Diversity: 1.6
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14477828', '11434154', '15376243', '14867554', '12467214']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6118625068233232
- 35 USC 102 Novelty (BERT): 0.6267114428665983
- Combined Prediction Score: 0.6133474004276508
- Mean Citation Score: 365.43693
- Max Citation Score: 703.2847
- Similarity Product: 494.3462300005794

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test